213 related articles for article (PubMed ID: 14718436)
1. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
2. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
3. Correlation between levels of tumour necrosis factor-alpha and levels of pH, glucose, and lactate dehydrogenase in parapneumonic effusions.
Odeh M; Sabo E; Srugo I; Oliven A
J Infect; 2005 Feb; 50(2):114-9. PubMed ID: 15667911
[TBL] [Abstract][Full Text] [Related]
4. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.
Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM
Lung; 2014 Aug; 192(4):577-81. PubMed ID: 24913743
[TBL] [Abstract][Full Text] [Related]
6. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
Heffner JE; Brown LK; Barbieri C; DeLeo JM
Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
[TBL] [Abstract][Full Text] [Related]
7. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
[TBL] [Abstract][Full Text] [Related]
8. Childhood parapneumonic effusions: biochemical and inflammatory markers.
Utine GE; Ozcelik U; Yalcin E; Dogru D; Kiper N; Aslan A; Kanra G
Chest; 2005 Sep; 128(3):1436-41. PubMed ID: 16162740
[TBL] [Abstract][Full Text] [Related]
9. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.
Yang CY; Kuo YH; Chen M; Wang CL; Shih LJ; Liu YC; Hsueh PC; Lai YH; Chu CM; Wu CC; Wu KA
Sci Rep; 2021 Jan; 11(1):1763. PubMed ID: 33469074
[TBL] [Abstract][Full Text] [Related]
10. The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
Odeh M; Makhoul B; Sabo E; Srugo I; Oliven A
Lung; 2005; 183(1):13-27. PubMed ID: 15793664
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin-8 in differentiation of uncomplicated from complicated parapneumonic effusion.
Petrusevska Marinkovic S; Kondova Topuzovska I; Milenkovic Z; Kondov G; Bosevska G; Anastasovska A
Prilozi; 2011; 32(1):101-11. PubMed ID: 21822181
[TBL] [Abstract][Full Text] [Related]
13. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
14. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
[TBL] [Abstract][Full Text] [Related]
15. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Maskell NA; Gleeson FV; Darby M; Davies RJ
Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
[TBL] [Abstract][Full Text] [Related]
16. [From pneumonic infiltration to parapneumonic effusion--from effusion to pleural empyema: internal medicine aspects of parapneumonic effusion development and pleural empyema].
Domej W; Wenisch C; Demel U; Tilz GP
Wien Med Wochenschr; 2003; 153(15-16):349-53. PubMed ID: 13677257
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid tests to identify complicated parapneumonic effusions.
Porcel JM
Curr Opin Pulm Med; 2010 Jul; 16(4):357-61. PubMed ID: 20224408
[TBL] [Abstract][Full Text] [Related]
18. Measurement of lactate in pleural fluid rapidly identify infection and guide therapy.
Johansson N; Andersson Ydsten K; Backman-Johansson C; Vondracek M; Hedlund J
Infect Dis (Lond); 2023 Jun; 55(6):396-404. PubMed ID: 37021765
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Pleural Fluid Lactate for Diagnosis and Management of Parapneumonic Pleural Effusion.
Santotoribio JD; Alnayef-Hamwie H; Batalha-Caetano P; Perez-Ramos S; Pino MJ
Clin Lab; 2016 Sep; 62(9):1683-1687. PubMed ID: 28164581
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor necrosis factor-alpha in the differential diagnosis of parapneumonic effusion.
Odeh M; Sabo E; Oliven A; Srugo I
Int J Infect Dis; 2000; 4(1):38-41. PubMed ID: 10689213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
